VELIN-PHARMA A/S: Financial statements 2014
CVR: 33026013
Source: annual report 2014, Danish Business Authority
01/06/2013 – 31/05/2014
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 299,250 and a net result of DKK 1,952,211 compared with DKK 1,088,826 the year before. That is an increase of 318.2% compared with the year before. Equity in the 2014 report amounted to DKK 17,827,130. The solvency ratio was 92.9%.
- Gross Profit
- DKK 299,250
- Profit/Loss
- DKK 1,952,211
- Equity
- DKK 17,827,130
- Total Assets
- DKK 19,179,952
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 299 t. | 2 mio. | 17.8 mio. | - |
| 2013 | - | 72 t. | 1.1 mio. | 15.9 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.